Archive for the ‘co-pay’ tag
Copywriting – How do “other” brands mention they’ll help pay for drugs
So you’re writing copy for this new ad. The client wants to include a mention that their company can help patients with the drug cost…
Lipitor co-pay card makes debut and allows patients to save money in the US
Lipitor, the biggest blockbuster ever, is getting more aggressive with it’s marketing offering a promotion that save current Lipitor users money regardless of their income. While most insurance premiums and co-pays are going up this handy card could ensure that patients on Lipitor stay on Lipitor instead of generic equivalents.
Read the tory on World of DTC marketing
See this ad and other Lipitor ads on AdPharm
Crestor – TV commercial
Description: A man talks on-screen about the dangers of high cholesterol that may cause plaque buildup. He then invites viewers to visit Arterytour.com to get additional information via their interactive online tour. Arterytour.com is a comprehensive sales-pitch site for Crestor. Whats new about this site is that it uses a form of augmented reality to educate people about high cholesterol and plaque buildup.
Click here to visit the site.
To see all of the ads from this campaign, click here
Brand name: Crestor
Generic name/category: Rosuvastatin, statins
Company: AstraZeneca
Country/Market: USA, North America
Indication(s)/use: high LDL cholesterol (dyslipidemia), total cholesterol (hypercholesterolemia) and/or triglycerides (hypertriglyceridemia)
Target: Consumer (DTC)
Medium: TV commercial
Size/duration: 60 seconds
Publication: 2009
To see all Crestor ads, click here
From Wikipedia:
Rosuvastatin is a member of the drug class of statins, used to treat high cholesterol and related conditions, and to prevent cardiovascular disease. Shionogi developed the product and the pharmaceutical company AstraZeneca markets it as Crestor.
Rosuvastatin is approved for the treatment of high LDL cholesterol (dyslipidemia), total cholesterol (hypercholesterolemia) and/or triglycerides (hypertriglyceridemia).
As of 2004, rosuvastatin had been approved in 154 countries and launched in 56. Approval in the United States by the FDA came on August 12, 2003.
Click here to see the details and full-size version of this ad on AdPharm
This ad and thousands more can be seen on the AdPharm gallery, the largest online pharmaceutical advertising gallery.
Crestor – Building your life TV commercial
Description: People from different walks of life talk about cholesterol and how much they thought they knew about it and in reality they don’t. A spokesperson then comes in and talks about the risks associated with high cholesterol and its link with plaque buildup using animated visuals…
To see all of the ads from this campaign, click here
Brand name: Crestor
Generic name/category: Rosuvastatin, statins
Company: AstraZeneca
Country/Market: USA, North America
Indication(s)/use: high LDL cholesterol (dyslipidemia), total cholesterol (hypercholesterolemia) and/or triglycerides (hypertriglyceridemia)
Target: Consumer (DTC)
Medium: TV commercial
Size/duration: 60 seconds
Publication: 2009
To see all Crestor ads, click here
From Wikipedia:
Rosuvastatin is a member of the drug class of statins, used to treat high cholesterol and related conditions, and to prevent cardiovascular disease. Shionogi developed the product and the pharmaceutical company AstraZeneca markets it as Crestor.
Rosuvastatin is approved for the treatment of high LDL cholesterol (dyslipidemia), total cholesterol (hypercholesterolemia) and/or triglycerides (hypertriglyceridemia).
As of 2004, rosuvastatin had been approved in 154 countries and launched in 56. Approval in the United States by the FDA came on August 12, 2003.
Click here to see the details and full-size version of this ad on AdPharm
AdPharm is the largest online pharmaceutical advertising gallery. It is subscription-based with various subscriptions plans available here.
Crestor – Building your life TV commercials
Click here to see the details and full-size versions of this ad on AdPharm
AdPharm is the largest online pharmaceutical advertising gallery. It is subscription-based with various subscriptions plans available here.
Nexium – 50 states
50 states. 1 healing purple pill a day.
The majority of patients with prescription drug coverage for Nexium pay $30 or less per month
Brand name: Nexium
Generic name/category: esomeprazole, Proton pump inhibitors (PPI)
Company: AstraZeneca
Country/Market: USA, North America
Indication(s)/use: prevent the formation of gastric acid
Target: Direct to consumer (DTC)
Medium: Print ad
Size/duration: Single-page
Publication/Aired: Reader's Digest – February 2009
To see all of this brand's ads on AdPharm, click here
From Wikipedia:
Esomeprazole is a proton pump inhibitor (brand names Sompraz, Zoleri, Nexium??, Lucen, Esopral; Axagon in Italy, Nexiam in Belgium) developed and marketed by AstraZeneca which is used in the treatment of dyspepsia, peptic ulcer disease (PUD), gastroesophageal reflux disease (GORD/GERD) and Zollinger-Ellison syndrome. Esomeprazole is the S-enantiomer of omeprazole (marketed as Losec/Prilosec), and AstraZeneca claims improved efficacy of this single enantiomer product over the racemic mixture of omeprazole. However, this greater efficacy has been disputed, with some claiming it offers no benefit from its older form.
Click here to see the details and full-size version of this ad on AdPharm
AdPharm is the largest online pharmaceutical advertising gallery. It is subscription-based with various subscriptions plans available here.
Vytorin – print ad
There are 2 sources of cholesterol. Food & Family.
Only Vytorin treats both.
Brand name: Vytorin
Generic name/category: Ezetimibe/simvastatin, Statins
Company: Merck/Schering-Plough Pharmaceuticals
Country/Market: USA, North America
Indication(s)/use: treatment of dyslipidemia
Target: Consumers (DTC)
Tagline: Treat the 2 sources of cholesterol
Medium: Print ad
Size/duration: Double-page spread
Publication/Aired: Prevention – December 2009
To see all of this brand's ads on AdPharm, click here
Ezetimibe/simvastatin is a drug combination used for the treatment of dyslipidemia. It is a combination of ezetimibe (best known as Zetia in the United States and Ezetrol elsewhere) and the statin drug simvastatin (best known as Zocor in the U.S.). The combination preparation is marketed by Merck & Co./Schering-Plough Pharmaceuticals (joint venture) under the trade names Vytorin and Inegy.
Ezetimibe reduces blood cholesterol by inhibiting absorption of cholesterol by the small intestine by acting at the brush border of the small intestine and inhibits the absorption of cholesterol, leading to a decrease in the delivery of intestinal cholesterol to the liver.
Simvastatin is an HMG-CoA reductase inhibitor or statin. It works by blocking an enzyme that is necessary for the body to make cholesterol.
Click here to see the details and full-size version of this ad on AdPharm
AdPharm is the largest online pharmaceutical advertising gallery. It is subscription-based with various subscriptions plans available here.
